13 employees
Toleranzia AB is a technology portfolio for treatment of autoimmune diseases
2011
$82K
from 1 investors over 1 rounds
Toleranzia AB raised $82K on January 1, 2019
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)